Ventria Bioscience acquires Meristem Therapeutics' Recombinant Lactoferrin IP

Ventria Bioscience acquires Meristem Therapeutics' Recombinant Lactoferrin IP

FORT COLLINS - Ventria Bioscience will wholly acquire portions of the intellectual property portfolio relating to Recombinant Lactoferrin developed by the French biotech company Meristem... Read More

By: Steve Tuesday December 4, 2012 Tags: ExpressTec, Fort Collins, Scott Deeter, VEN100, Ventria Bioscience

IN Sponsors

Content Garden ad

Browse

InnovatioNews ends 9-year run covering Colorado innovation
A New Sunrise. Stakeholders all await, shapes a path to success too few even see. How often you get & answer questions is one indicator of your readiness
A New Sunrise. Stakeholders all await, shapes a path to success too few even see. How often you get & answer questions is one indicator of your readiness
InnovatioNews on Spring hiatus until May 13
InnovatioNews on Spring hiatus until May 13
The Coming Drone Delivery Revolution – What Comes Next?
The Coming Drone Delivery Revolution – What Comes Next?
Primavera Essentials introduces Neuro-Eze
Primavera Essentials introduces Neuro-Eze

Entrepreneurial by Nature


Colorado Entreprenerial by Nature
Copyright InnovatioNews LLC 2015. All Rights Reserved.